Comparison of clinical effects between rosiglitazone and pioglitazone in the treatment of type 2 diabetes of eldly patients
Jiao Sun
Abstract
Jiao Sun
Abstract
AIM To compare the clinical effects of rosiglitazone with pioglitazone in the treatment of type 2 dia- betic patients.METHODS Sixty-four patients who had been treated with food control,exercise and fixed oral anti-dia- betic drugs for one month,but their fasting plasma glucose level was still over 7 mmol·L~(-1).They were randomized divid- ed into two groups.One was added with rosiglitazone,the other was added with pioglitazone.All of them were treated for 12 weeks.RESULTS After treatment for 12 weeks,①patient's fasting plasma glucose,postprandial plasma glucose, HbA_(?)c and insulin resistance index were significant decreased in both groups;②triglyceride and total cholesterol were decreased in pioglitazone group(P0.05),but those in rosiglitazone group were no significant reduction(P0.05);③high density lipoprotein-cholesterol was elevated in both groups(P0.05).CONCLUSION Rosiglitazone or pioglita- zone can be used to control blood glucose,but pioglitazone shows more efficiency on triglyceride control.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM To compare the clinical effects of rosiglitazone with pioglitazone in the treatment of type 2 dia- betic patients.METHODS Sixty-four patients who had been treated with food control,exercise and fixed oral anti-dia- betic drugs for one month,but their fasting plasma glucose level was still over 7 mmol·L~(-1).They were randomized divid- ed into two groups.One was added with rosiglitazone,the other was added with pioglitazone.All of them were treated for 12 weeks.RESULTS After treatment for 12 weeks,①patient's fasting plasma glucose,postprandial plasma glucose, HbA_(?)c and insulin resistance index were significant decreased in both groups;②triglyceride and total cholesterol were decreased in pioglitazone group(P0.05),but those in rosiglitazone group were no significant reduction(P0.05);③high density lipoprotein-cholesterol was elevated in both groups(P0.05).CONCLUSION Rosiglitazone or pioglita- zone can be used to control blood glucose,but pioglitazone shows more efficiency on triglyceride control.
Key concepts: Pioglitazone, Rosiglitazone, Postprandial, Internal medicine, Medicine, Triglyceride, Endocrinology, Type 2 diabetes